Zepoxin 40mg Injection contains Pantoprazole, a proton pump inhibitor indicated for the treatment of conditions involving excessive gastric acid secretion. This medication is primarily used in the management of gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and erosive esophagitis. Pantoprazole acts by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing the final step in acid production. This leads to a significant reduction in gastric acid secretion, promoting healing of acid-related damage and providing symptomatic relief. Zepoxin 40mg Injection is administered intravenously, offering an alternative route for patients unable to take oral formulations or requiring rapid acid suppression. The injection should be administered under medical supervision, with dosage and duration tailored to the specific clinical condition and patient response. Common adverse effects may include headache, diarrhea, nausea, and abdominal pain, though it is generally well tolerated. Caution is advised in patients with hepatic impairment, and monitoring is recommended during prolonged therapy. Zepoxin 40mg Injection is contraindicated in patients with known hypersensitivity to pantoprazole or other proton pump inhibitors. Proper use of this medication contributes to effective management of acid-related gastrointestinal disorders.